An analysis of drug modulation of abdominal aortic aneurysm growth through 25 years of surveillance

Journal of Vascular Surgery

Volumn 52, Issue 1, 2010, Pages

  Thompson, Andrew ^a,b   Cooper, Jackie A ^b   Fabricius, Michael ^a   Humphries, Steve E ^b   Ashton, Hilary A ^a   Hafez, Hany ^a  

^a UK   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; BIGUANIDE; INSULIN; POTASSIUM SPARING DIURETIC AGENT; SULFONYLUREA;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; DATA BASE; DEATH; DIABETES CONTROL; DIABETES MELLITUS; DISEASE SURVEILLANCE; DRUG EFFECT; FEMALE; GROWTH RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYPHARMACY; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SEX DIFFERENCE; SMOKING; TREATMENT OUTCOME;

EID: 77953669872     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.02.012     Document Type: Article

References (21)

1. Ashton H., Buxton M.J., Day N.E., Kim L.G., Marteau T.M., Scott R.A., et al. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 360 (2002) 1531-1539
2. Lederle F.A., Wilson S.E., Johnson G.R., Reinke D.B., Littooy F.N., Acher C.W., et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 346 (2002) 1437-1444
3. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants. Lancet 352 (1998) 1649-1655
4. Thompson A.R., Cooper J.A., Ashton H.A., and Hafez H. Growth rates of small abdominal aortic aneurysms correlate with clinical events. Br J Surg 97 (2010) 37-44
5. Golledge J., and Powell J.T. Medical management of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 34 (2007) 267-273
6. Choke E., Cockerill G., Wilson W.R., Sayed S., Dawson J., Loftus I., et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 30 (2005) 227-244
7. Baxter B.T., Terrin M.C., and Dalman R.L. Medical management of small abdominal aortic aneurysms. Circulation 117 (2008) 1883-1889
8. Hackam D.G., Thiruchelvam D., and Redelmeier D.A. Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study. Lancet 368 (2006) 659-665
9. Brady A.R., Thompson S.G., Fowkes F.G., Greenhalgh R.M., and Powell J.T. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 110 (2004) 16-21
10. Browne W.J. MCMC Estimation in MLwiN, v2.10 (2009), Centre for Multilevel Modelling, University of Bristol
11. Mofidi R., Goldie V.J., Kelman J., Dawson A.R., Murie J.A., and Chalmers R.T. Influence of sex on expansion rate of abdominal aortic aneurysms. Br J Surg 94 (2007) 310-314
12. Solberg S., Singh K., Wilsgaard T., and Jacobsen B.K. Increased growth rate of abdominal aortic aneurysms in women. The Tromso study. Eur J Vasc Endovasc Surg 29 (2005) 145-149
13. Santilli S.M., Littooy F.N., Cambria R.A., Rapp J.H., Tretinyak A.S., d'Audiffret A.C., et al. Expansion rates and outcomes for the 3.0-cm to the 3.9-cm infrarenal abdominal aortic aneurysm. J Vasc Surg 35 (2002) 666-671
14. Gomez R., Estallo L., Rodriguez L., Baquer M., and Barba A. Growth rate and associated factors in small abdominal aortic aneurysms. Vega dC. Eur J Vasc Endovasc Surg 31 (2006) 231-236
15. Daugherty A., Manning M.W., and Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105 (2000) 1605-1612
16. Cassis L.A., Helton M.J., Howatt D.A., King V.L., and Daugherty A. Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Br J Pharmacol 144 (2005) 443-448
17. Lu H., Rateri D.L., Cassis L.A., and Daugherty A. The role of the renin-angiotensin system in aortic aneurysmal diseases. Curr Hypertens Rep 10 (2008) 99-106
18. Sukhija R., Aronow W.S., Sandhu R., Kakar P., and Babu S. Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol 97 (2006) 279-280
19. Schouten O., van Laanen J.H., Boersma E., Vidakovic R., Feringa H.H., Dunkelgrun M., et al. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg 32 (2006) 21-26
20. Perneger T.V. What's wrong with Bonferroni adjustments. BMJ 316 (1998) 1236-1238
21. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1 (1990) 43-46